Secure data from more than 14,000 adults who participate in National Institutes of Health observational research on long Covid are now available to authorized researchers through BioData Catalyst (BDC ...
To help advance myopia management as a standard of care, the World Council of Optometry (WCO) is partnering with CooperVision, a global leader in myopia management, to introduce an interactive and ...
Hookipa Pharma Inc., a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced its final pivotal phase 2/3 trial design for HB-200 in combination ...
EMA committee adopts positive opinion for Biogen’s Tofidence, a biosimilar monoclonal antibody referencing Roactemra: Cambridge, Massachusetts Saturday, April 27, 2024, 17:00 Hr ...
Anacon India emerges as leading platform in western region: Our Bureau, Mumbai Saturday, April 27, 2024, 16:30 Hrs [IST] The recent Mumbai edition of analytica Anacon In ...
US FDA approves Medtronic’s Inceptiv closed-loop spinal cord stimulator: Dublin Saturday, April 27, 2024, 15:00 Hrs [IST] Medtronic plc, a global leader in healthcare technology ...
AIOCD opposes Centre’s proposed move to allow OTC drug sales at general stores: Our Bureau, Mumbai Saturday, April 27, 2024, 13:15 Hrs [IST] The All India Organisation of Chemis ...
Applied DNA Sciences, Inc. (Applied DNA), a leader in PCR-based DNA technologies, announced the award of a contract from HDT Bio for the purpose of rapid, next-generation vaccine development under a ...
Compass gets US FDA fast track status for its bispecific DLL4/VEGF-A antibody, CTX-009 in combo with paclitaxel to treat biliary tract cancers: Boston Saturday, April 27, 2024, 12 ...
Soligenix extends patent protection for its Filovirus vaccine to United Kingdom and South Africa: Princeton, New Jersey Saturday, April 27, 2024, 11:00 Hrs [IST] Soligenix, Inc, a ...
US FDA approves Freedom Biosciences’ IND application for FREE001 in patients with treatment-resistant depression: San Francisco Saturday, April 27, 2024, 10:00 Hrs [IST] Freedom ...
Regeneron, Mammoth Biosciences collaborate to pursue next-generation CRISPR-based gene editing for multiple diseases: Tarrytown, New York Saturday, April 27, 2024, 09:00 Hrs [IST] ...